DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

Drugs Controller General of India has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in......

Uzbek syrup deaths: India begins probe, manufacturing halted

The manufacturing of Marion Biotech's Dok-1 Max has stopped “for now”, the company's legal representative said on Thursday as the Central Drugs Standard Control Organisation began a......

WHO rejects SII's proposal to extend Covishield's shelf life

The World Health Organisation has rejected Serum Institute of India's proposal seeking extension of the shelf life of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from six to nine months,......

WHO wrong in linking Gambia kids deaths to Indian cough syrups: DCGI

The World Health Organisation drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical......